| 臺大學術典藏 |
2022-03-10T05:59:48Z |
Neuropsychiatric disturbances and hypopituitarism after traumatic brain injury in an elderly man
|
YI-CHENG CHANG; Tsai J.-C.; Tseng F.-Y. |
| 臺大學術典藏 |
2022-03-10T06:09:56Z |
UNC13D mutation presenting as fulminant familial hemophagocytic lymphohistiocytosis
|
Liao, Chun-Hua; NI-CHUNG LEE; Jou, Shiann-Tarng; Chiang, Bor-Luen; Yu, Hsin-Hui |
| 臺大學術典藏 |
2022-03-10T06:14:07Z |
Short stature leads to a diagnosis of Jansen-de Vries syndrome in two unrelated Taiwanese girls: A case report and literature review
|
Tsai, Meng-Ju Melody; NI-CHUNG LEE; Chien, Yin-Hsiu; Hwu, Wuh-Liang; Tung, Yi-Ching |
| 臺大學術典藏 |
2022-03-10T06:14:58Z |
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia
|
Lin C.-H.; Huang R.Y.-J.; Lu T.-P.; Kuo K.-T.; Lo K.-Y.; Chen C.-H.; Chen I.-C.; YEN-SHEN LU; Chuang E.Y.; Thiery J.P.; Huang C.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-10T06:14:59Z |
An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast Cancer
|
YEN-SHEN LU; Yeo W.; Yap Y.-S.; Park Y.H.; Tamura K.; Li H.; Cheng R. |
| 臺大學術典藏 |
2022-03-10T06:14:59Z |
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
|
Dai M.S.; Feng Y.H.; Chen S.W.; Masuda N.; Yau T.; Chen S.T.; YEN-SHEN LU; Yap Y.S.; Ang P.C.S.; Chu S.C.; Kwong A.; Lee K.S.; Ow S.; Kim S.B.; Lin J.; Chung H.C.; Ngan R.; Kok V.C.; Rau K.M.; Sangai T.; Ng T.Y.; Tseng L.M.; Bryce R.; Bebchuk J.; Chen M.C.; Hou M.F. |
| 臺大學術典藏 |
2022-03-10T06:14:59Z |
Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
|
YEN-SHEN LU; Wong A.; Kim H.-J. |
| 臺大學術典藏 |
2022-03-10T06:14:59Z |
Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients
|
Chen I.-C.; Hu F.-C.; Lin C.-H.; Huang S.-M.; Chang D.-Y.; Cheng A.-L.; YEN-SHEN LU |
| 臺大學術典藏 |
2022-03-10T06:15:00Z |
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs
|
Hata T.; Nakamura K.; Yonemori K.; Noguchi E.; Watanabe M.; Sohn J.; YEN-SHEN LU; Yap Y.-S.; Tamura K.; Fujiwara Y. |
| 臺大學術典藏 |
2022-03-10T06:15:00Z |
Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic components
|
Lien H.-C.; Lee Y.-H.; Chen I.-C.; Lin C.-H.; Chen T.W.-W.; Lu Y.-T.; YEN-SHEN LU |
| 臺大學術典藏 |
2022-03-10T06:15:00Z |
Matching-adjusted indirect comparison of ribociclib plus fulvestrant versus palbociclib plus letrozole as first-line treatment of hr+/her2? advanced breast cancer
|
Fasching P.A.; Delea T.E.; YEN-SHEN LU; De Boer R.; Hurvitz S.A.; Moynahan A.; Chandiwana D.; Lanoue B.; Hu H.; Thuerigen A.; O��shaughnessy J. |
| 臺大學術典藏 |
2022-03-10T06:15:01Z |
Genomic profiling of premenopausal HR+ and HER2�V metastatic breast cancer by circulating tumor DNA and association of genetic alterations with therapeutic response to endocrine therapy and ribociclib
|
Bardia A.; Su F.; Solovieff N.; Im S.-A.; Sohn J.; Lee K.S.; Campos-Gomez S.; Jung K.H.; Colleoni M.; V?zquez R.V.; Franke F.; Hurvitz S.; Harbeck N.; Chow L.; Taran T.; Lorenc K.R.; Babbar N.; Tripathy D.; YEN-SHEN LU |
| 臺大學術典藏 |
2022-03-10T06:15:01Z |
Role of alpelisib in the treatment of pik3ca-mutated breast cancer: Patient selection and clinical perspectives
|
Chang D.-Y.; Ma W.-L.; YEN-SHEN LU |
| 臺大學術典藏 |
2022-03-10T06:22:49Z |
Outcome of Later-Onset Pompe Disease Identified Through Newborn Screening
|
NI-CHUNG LEE; Chang, Kai-Ling; In 't Groen, Stijn L M; de Faria, Douglas O S; Huang, Hsiang-Ju; Pijnappel, W W M Pim; Hwu, Wuh-Liang; Chien, Yin-Hsiu |
| 臺大學術典藏 |
2022-03-10T06:39:34Z |
Identification of a wide spectrum of ciliary gene mutations in nonsyndromic biliary atresia patients implicates ciliary dysfunction as a novel disease mechanism
|
Lam, Wai-Yee; Tang, Clara Sze-Man; So, Man-Ting; Yue, Haibing; Jacob Shujui Hsu; Chung, Patrick Ho-Yu; Nicholls, John M; Yeung, Fanny; Lee, Chun-Wai Davy; Ngo, Diem Ngoc; Nguyen, Pham Anh Hoa; Mitchison, Hannah M; Jenkins, Dagan; O'Callaghan, Christopher; Garcia-Barceló, Maria-Mercè; Lee, So-Lun; Sham, Pak-Chung; Lui, Vincent Chi-Hang; Tam, Paul Kwong-Hang |
| 臺大學術典藏 |
2022-03-10T06:40:35Z |
A joint study of whole exome sequencing and structural MRI analysis in major depressive disorder
|
Zhang, Yamin; Li, Mingli; Wang, Qiang; Jacob Shujui Hsu; Deng, Wei; Ma, Xiaohong; Ni, Peiyan; Zhao, Liansheng; Tian, Yang; Sham, Pak Chung; Li, Tao |
| 臺大學術典藏 |
2022-03-10T07:58:34Z |
Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort
|
Chen K.-H.; Lin L.-I.; Yuan C.-T.; LI-HUI TSENG; Chao Y.-L.; Liang Y.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-10T07:58:35Z |
Clonal Origin Evaluated by Trunk and Branching Drivers and Prevalence of Mutations in Multiple Lung Tumor Nodules
|
Rodriguez E.F.; LI-HUI TSENG; De Marchi F.; Haung J.; Belchis D.; Xian R.; Gocke C.D.; Eshleman J.R.; Illei P.B.; Lin M.-T. |
| 臺大學術典藏 |
2022-03-10T07:58:35Z |
Multiclonal colorectal cancers with divergent histomorphological features and RAS mutations: one cancer or separate cancers?
|
Lin M.-T.; Zheng G.; LI-HUI TSENG; Zhang P.; Ling H.; Azad N.; Gocke C.D.; Montgomery E.; Eshleman J.R. |
| 臺大學術典藏 |
2022-03-10T07:58:35Z |
Clinical Validation of Discordant Trunk Driver Mutations in Paired Primary and Metastatic Lung Cancer Specimens
|
LI-HUI TSENG; De Marchi F.; Pallavajjalla A.; Rodriguez E.; Xian R.; Belchis D.; Gocke C.D.; Eshleman J.R.; Illei P.; Lin M.-T. |
| 臺大學術典藏 |
2022-03-10T07:58:36Z |
Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing
|
Lokhandwala P.M.; LI-HUI TSENG; Rodriguez E.; Zheng G.; Pallavajjalla A.; Gocke C.D.; Eshleman J.R.; Lin M.-T. |
| 臺大學術典藏 |
2022-03-10T07:58:36Z |
Clinical validation of coexisting driver mutations in colorectal cancers
|
Zheng G.; LI-HUI TSENG; Haley L.; Ibrahim J.; Bynum J.; Xian R.; Gocke C.D.; Eshleman J.R.; Lin M.-T. |
| 臺大學術典藏 |
2022-03-10T07:58:36Z |
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
|
Chen K.-H.; Lin L.-I.; LI-HUI TSENG; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-10T07:58:36Z |
Prediction Model for Audiological Outcomes in Patients with GJB2 Mutations
|
Chen P.-Y.; Lin Y.-H.; Liu T.-C.; Lin Y.-H.; LI-HUI TSENG; Yang T.-H.; Chen P.-L.; Wu C.-C.; Hsu C.-J. |
| 臺大學術典藏 |
2022-03-10T07:58:37Z |
A panel of 130 autosomal single-nucleotide polymorphisms for ancestry assignment in five Asian populations and in Caucasians
|
Hwa H.-L.; Lin C.-P.; Huang T.-Y.; Kuo P.-H.; Hsieh W.-H.; Lin C.-Y.; Yin H.-I.; LI-HUI TSENG; Lee J.C.-I. |
